Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OSAT: Optimal Sensing in Atrial Tachyarrhythmia's Study

NCT01074749 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01074749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01074749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OSAT: Optimal Sensing in Atrial Tachyarrhythmia's Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2010
Completion date
July 31, 2014
Enrollment
111 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, sick sinus syndrome